Number of ANDAs received in U.S. 2009-2023
This statistic depicts the number of abbreviated new drug applications (ANDAs) received in the United States from 2009 to 2023. In 2023, 733 ANDAs were received, compared to over 1,300 ANDAs in 2017.
Number of abbreviated new drug applications (ANDA) received in the U.S. from 2009 to 2023
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$959 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Generics and biosimilars
Global overview
5
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2023
- Basic Statistic Generic drugs market size worldwide 2023-2033
- Premium Statistic Global market forecast of biosimilars 2023-2033
- Basic Statistic Worldwide Rx drug revenue - market at risk from patent expiration 2024-2030
- Basic Statistic Market share of generics in European countries 2022
Top companies
5
- Premium Statistic Revenues of leading global generics manufacturers 2023
- Premium Statistic Teva Pharmaceutical Industries' generic revenues by region 2016-2023
- Premium Statistic Sandoz net sales 2014-2023 by segment
- Premium Statistic Viatris revenue 2019-2023
- Premium Statistic Sun Pharma's income FY 2010-2024
U.S. market
6
- Premium Statistic Number of ANDAs received in U.S. 2009-2023
- Premium Statistic U.S. brand and generic prescription drug spending 2020-2023
- Premium Statistic Branded vs. generic U.S. drug prescriptions dispensed 2020-2023
- Premium Statistic Generic drugs revenue top corporations in the U.S. 2023
- Premium Statistic Generics market share of top corporations in the U.S. 2023
- Premium Statistic Top pharma products by prescriptions U.S. 2022
Patent expiration
3
Savings
7
- Premium Statistic Savings through generic drug usage in the U.S. 2008-2023
- Premium Statistic Total savings of top generic drugs in U.S. 2023
- Premium Statistic Saving of U.S. costs through generic pharmaceuticals by condition 2023
- Basic Statistic Savings through generic drug usage in the U.S., by age group 2023
- Basic Statistic Savings through generic drug usage in the U.S., by payer 2023
- Basic Statistic Percentage savings through generic drug usage in the U.S. by payer 2023
- Basic Statistic Savings through generic drug usage in the U.S., by age group share 2023
Biosimilars
7
- Premium Statistic Global market share of biosimilars by region 2023
- Basic Statistic Number of biosimilars approved by FDA 2015-2023
- Basic Statistic New U.S. biosimilar launches of top products 2024-2029
- Premium Statistic Adalimumab wholesale acquisition cost in the U.S. 2024
- Premium Statistic Share of adalimumab sales Humira vs. biosimilars U.S. 2024
- Premium Statistic Share of filgrastim sales attributable to Neupogen or biosimilars US 2015-2024
- Premium Statistic Share of insuline glargine sales Lantus vs. biosimilar US 2015-2024
Further related statistics
10
- Merck & Co - expenditure on research and development 2006-2023
- Cvs Health total assets 2019-2023
- Annual revenue of Sinopharm 2010-2022
- Number of employees at Sinopharm 2011-2022
- Key figures on established biotech centers worldwide 2012-2016
- Global pharmaceutical pipeline by therapy area 2013-2017
- Merck & Co total assets 2019-2023
- Merck & Co cash dividends declared 2006-2023
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
Further Content: You might find this interesting as well
Statistics
- Merck & Co - expenditure on research and development 2006-2023
- Cvs Health total assets 2019-2023
- Annual revenue of Sinopharm 2010-2022
- Number of employees at Sinopharm 2011-2022
- Key figures on established biotech centers worldwide 2012-2016
- Global pharmaceutical pipeline by therapy area 2013-2017
- Merck & Co total assets 2019-2023
- Merck & Co cash dividends declared 2006-2023
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$959 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Association for Accessible Medicines, & IQVIA. (February 6, 2024). Number of abbreviated new drug applications (ANDA) received in the U.S. from 2009 to 2023 [Graph]. In Statista. Retrieved December 04, 2024, from https://www.statista.com/statistics/864366/andas-received-number/
Association for Accessible Medicines, und IQVIA. "Number of abbreviated new drug applications (ANDA) received in the U.S. from 2009 to 2023." Chart. February 6, 2024. Statista. Accessed December 04, 2024. https://www.statista.com/statistics/864366/andas-received-number/
Association for Accessible Medicines, IQVIA. (2024). Number of abbreviated new drug applications (ANDA) received in the U.S. from 2009 to 2023. Statista. Statista Inc.. Accessed: December 04, 2024. https://www.statista.com/statistics/864366/andas-received-number/
Association for Accessible Medicines, and IQVIA. "Number of Abbreviated New Drug Applications (Anda) Received in The U.S. from 2009 to 2023." Statista, Statista Inc., 6 Feb 2024, https://www.statista.com/statistics/864366/andas-received-number/
Association for Accessible Medicines & IQVIA, Number of abbreviated new drug applications (ANDA) received in the U.S. from 2009 to 2023 Statista, https://www.statista.com/statistics/864366/andas-received-number/ (last visited December 04, 2024)
Number of abbreviated new drug applications (ANDA) received in the U.S. from 2009 to 2023 [Graph], Association for Accessible Medicines, & IQVIA, February 6, 2024. [Online]. Available: https://www.statista.com/statistics/864366/andas-received-number/